
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2022-2030
An essential study technique for comprehending biological processes in vivo and in real-time is bioluminescence imaging (BLI). Low signal-to-noise ratio (SNR), great sensitivity, and the ability to study processes in vivo without endangering the subject animal are some of the primary advantages of bioluminescence imaging.
Compared to more conventional imaging and biodistribution research using terminal endpoints, invasive procedures, or radiolabeling, bioluminescence imaging offers a reliable, sensitive, and high throughput alternative.
The Global Bioluminescence imaging market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.
2D optical and 3D optical tomography are both included in the IVIS Spectrum in vivo imaging system. For non-invasive longitudinal monitoring of disease progression, cell trafficking, and gene expression patterns in living animals, the system makes use of cutting-edge optical technologies for preclinical imaging research and innovation. It boasts a 3.9 cm field of view, high resolution (to 20 microns), and high sensitivity in vivo imaging of fluorescence and bioluminescence.
With its faultless optical and X-ray imaging capabilities, the PerkinElmer IVIS Lumina III XR is the ideal imaging solution. A precise overlay to see bioluminescence or fluorescence map activities with anatomical surface or X-ray features is made possible by the system's Living Image software.
Even in the scientific community, a smartphone has immense imaging potential. Fluorescence tags have recently been used in biomolecular imaging on smartphones. Bioluminescence can be used in smartphone-based techniques to observe biological targets at different scales. A single cell's bioluminescence may be picked up by the smartphone microscope.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2022-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2022-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2022-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2022-2030 |
21 | Product installation rate by OEM, 2022 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2022 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |